Invention Grant
- Patent Title: Fully human antibodies to BTLA
-
Application No.: US14031319Application Date: 2013-09-19
-
Publication No.: US09346882B2Publication Date: 2016-05-24
- Inventor: Jennifer Marie Mataraza , Andrea Van Elsas , Alan J. Korman , Edward L. Halk , Kent B. Thudium , Mark J. Selby , Timothy W. Sproul , Heidi N. Leblanc
- Applicant: MEDAREX, L.L.C.
- Applicant Address: US NJ Princeton
- Assignee: E. R. SQUIBB & SONS, L.L.C.
- Current Assignee: E. R. SQUIBB & SONS, L.L.C.
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jill Gorny Sloper, Esq.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C12N15/11 ; C12N15/79 ; C12N15/00
Abstract:
The present invention relates to binding compounds specific for BTLA and uses thereof. More specifically, the invention relates to fully human antibodies that recognize human BTLA and modulate its activity in cancer, inflammatory, and autoimmune disorders.
Public/Granted literature
- US20140017255A1 FULLY HUMAN ANTIBODIES TO BTLA Public/Granted day:2014-01-16
Information query
